Today: 8 June 2026
Browse Category

NYSE:BAX 10 August 2025 - 30 April 2026

Baxter Stock Plummets 15% After Mixed Q3 Earnings – What Investors Should Know

Baxter Stock Plummets 15% After Mixed Q3 Earnings – What Investors Should Know

Baxter shares fell about 16% to $19 on Oct. 30 after cutting its 2025 outlook and missing Q3 sales forecasts. Q3 revenue rose 5% to $2.84 billion, but sales missed estimates; adjusted EPS of $0.69 beat expectations. The company halted Novum IQ infusion pump shipments after two patient deaths and reported hurricane-related supply disruptions. Andrew Hider became CEO in July.
30 October 2025
·
Breakthrough Cures, FDA Shake-Ups & Pharma Mega‑Deals: Global Health News Roundup (Aug 9–10, 2025)

Breakthrough Cures, FDA Shake-Ups & Pharma Mega‑Deals: Global Health News Roundup (Aug 9–10, 2025)

China researchers reported a hydrogel “smart” wound dressing that closed 90% of diabetic ulcers in mice within 12 days by delivering microRNA vesicles. The FDA approved Boehringer Ingelheim’s Hernexeos for advanced non-squamous NSCLC, with 75% of treated patients seeing tumors shrink or disappear. U.S. IV saline shortages ended as Baxter’s North Carolina plant resumed production after hurricane damage.
10 August 2025
······

Stock Market Today

  • 3Knights Dynamics Targets IPO with Ambitious Valuation
    June 8, 2026, 5:21 PM EDT. 3Knights Dynamics is preparing for an initial public offering (IPO) with an ambitious target valuation. Donovan Jones, an IPO specialist with 15 years of U.S. IPO analysis experience, highlights the company's growth prospects. Jones, who leads IPO Edge-an investment group providing detailed IPO insights-notes no personal financial ties to 3Knights Dynamics, ensuring unbiased commentary. The IPO aims to attract investors by leveraging growth stock trends and market interest. Investors are cautioned that past performance is not indicative of future results, and no investment advice is provided. This move marks a significant step for 3Knights Dynamics as it seeks capital and market presence through the public offering process.

Latest articles

Texxon Trading Halted Six Times as NPT Jumps 284% in New York

Texxon Trading Halted Six Times as NPT Jumps 284% in New York

8 June 2026
Texxon shares soared 283.7% to $4.95, briefly topping $12 before closing just below their $5 IPO price, with trading paused six times for volatility and volume over six times shares outstanding; the company warned that similar IPOs had seen sharp, non-fundamental price swings, highlighting ongoing risk for investors.
Social Security Payments Land This Week—June 10 Recipients

Social Security Payments Land This Week—June 10 Recipients

8 June 2026
Social Security’s retirement trust fund could force a 24% benefit cut by 2032, slashing average monthly payments by about $500 for retirees, according to the Committee for a Responsible Federal Budget, as the official trustees project full benefits only until 2033 and continuing income covering just 77% thereafter.
IonQ Jumps as Quantum IPO Rush Sets Wall Street Benchmark

IonQ Jumps as Quantum IPO Rush Sets Wall Street Benchmark

8 June 2026
IonQ surged 10.5% to $62.77, outpacing quantum peers after Quantinuum’s $1.68 billion Nasdaq IPO gave investors a new benchmark for trapped-ion quantum stocks; IonQ’s rally follows its May guidance raise and soaring revenue, but losses and a long commercialization timeline remain key risks.
Snap Shares Climb as Debt Markets Send Signal

Snap Drops Again as Wall Street Stays Wary

8 June 2026
Snap plunged 2.1% to $5.64, underperforming a tech rebound, as investors weighed improved cash flow and a recent S&P credit upgrade against ongoing ad-market pressure, cost cuts, and spending on Specs; the stock’s weakness stood out as peers like Pinterest gained, highlighting market doubts about Snap’s ability to sustain growth amid tough competition and uncertain ad budgets.
Go toTop